Login


Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?

Optum Assessing Impact of First Take-Home COVID Test

Wednesday, November 25, 2020 | 1463 | 0 | 297 min read

Optum Workers’ Comp and Auto No-Fault said it is evaluating the impact of a prescription at-home COVID-19 test kit on its standard formularies and viral infection supplemental formulary. The U.S. Food and Drug Administration on Nov. 17 authorized the use of the Lucira COVID-19 nasal swab test kit, Optum said. The single-use kit can be used at home for people 14 and older and for patients of any age in point-of-care settings including doctor offices, urgent care facilities and hospitals. Test results are displayed in less than 30 minutes. Lucira Health reportedly said it plans to make ...

Purchase this story for only $7.99!


For access to all of our articles, check out our subscription options.

Comments

Related Articles